Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Price

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|May 1, 1997
In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteersR C Allen, P R Stevens, T H Price, et al.
The New England Journal of Medicine|May 8, 1980
The cost effectiveness of therapeutic and prophylactic leukocyte transfusionM S Rosenshein, V T Farewell, T H Price, et al.
Transfusion|February 1, 1997
A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteersW C Liles, J E Huang, C Llewellyn, et al.
Transfusion|April 16, 1999
Frequency of immediate adverse effects associated with therapeutic apheresisB C McLeod, I Sniecinski, D Ciavarella, et al.
Blood|May 29, 2000
Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantationT H Price, R A Bowden, M Boeckh, et al.
Transfusion|October 13, 1998
Frequency of immediate adverse effects associated with apheresis donationB C McLeod, T H Price, H Owen, et al.
Cytokines, Cellular & Molecular Therapy|January 5, 2001
Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibodyW C Liles, D C Dale, T H Price, et al.
Vox Sanguinis|February 16, 2011
Preparation of granulocyte concentrates by apheresis: collection modalities in the USAR G Strauss, H G Klein, S F Leitman, et al.
Transfusion|July 1, 1985
Modified fluid gelatin. An alternative macromolecular agent for centrifugal leukapheresisD W Huestis, T J Loftus, R Gilcher, et al.
Clinical Immunology and Immunopathology|April 1, 1983
Chronic lymphocytosis with neutropenia: evidence for a novel, abnormal T-cell population associated with antibody-mediated neutrophil destructionG Starkebaum, P J Martin, J W Singer, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|May 1, 1997
In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteersR C Allen, P R Stevens, T H Price, et al.
The New England Journal of Medicine|May 8, 1980
The cost effectiveness of therapeutic and prophylactic leukocyte transfusionM S Rosenshein, V T Farewell, T H Price, et al.
Transfusion|February 1, 1997
A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteersW C Liles, J E Huang, C Llewellyn, et al.
Transfusion|April 16, 1999
Frequency of immediate adverse effects associated with therapeutic apheresisB C McLeod, I Sniecinski, D Ciavarella, et al.
Blood|May 29, 2000
Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantationT H Price, R A Bowden, M Boeckh, et al.
Transfusion|October 13, 1998
Frequency of immediate adverse effects associated with apheresis donationB C McLeod, T H Price, H Owen, et al.
Cytokines, Cellular & Molecular Therapy|January 5, 2001
Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibodyW C Liles, D C Dale, T H Price, et al.
Vox Sanguinis|February 16, 2011
Preparation of granulocyte concentrates by apheresis: collection modalities in the USAR G Strauss, H G Klein, S F Leitman, et al.
Transfusion|July 1, 1985
Modified fluid gelatin. An alternative macromolecular agent for centrifugal leukapheresisD W Huestis, T J Loftus, R Gilcher, et al.
Clinical Immunology and Immunopathology|April 1, 1983
Chronic lymphocytosis with neutropenia: evidence for a novel, abnormal T-cell population associated with antibody-mediated neutrophil destructionG Starkebaum, P J Martin, J W Singer, et al.
Pageof 10